eEFFECTOR Therapeutics, Inc. - Bathi resik saben saham sajrone 12 wulan pungkasan EFTR

Logo perusahaan publik eEFFECTOR Therapeutics, Inc. (EFTR)

eFFECTOR Therapeutics (EFTR) possesses high scientific authority in developing selective inhibitors for lung cancer therapy. The annual percentage growth of EPS TTM reflects current dynamics, with the value holding at -623.40. However, the business is currently winding down operations due to a funding shortage, while global conflicts are blocking logistics and the execution of critical international clinical trials.

effector.com (EFTR): Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 20.02.2024

eEFFECTOR Therapeutics Inc. - rincian analitis lan metrik utama (EFTR)

- rega saham lan konsensus proyeksi valuasi:
- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:eEFFECTOR Therapeutics
Barang utama eEFFECTOR Therapeutics, Inc.

The specifics of the eFFECTOR Therapeutics (EFTR) operating model are reflected in the annual dynamics of the EPS TTM metric. This indicator captures the percentage change in trailing twelve-month net income per share, with calculations based on a comparison of current results against the same period last year. For a company in the stage of program liquidation and liquidity shortages, such fluctuations reflect the capital burn rate. An increase in this metric does not signify efficiency here, but merely records the pace of loss reduction.